Tom Bergan
- Molecular Medicine top 0.5%
- Antibiotic Resistance in Bacteria 53
- Pharmacology top 0.2%
- Antibiotics Pharmacokinetics and Efficacy 118
- Hardware and Architecture top 1%
- Parallel Computing and Optimization Techniques 18
- Clinical Biochemistry top 1%
- Bacterial Identification and Susceptibility Testing 18
-
- Drug Transport and Resistance Mechanisms 19
-
- Pharmaceutical studies and practices 18
-
- Antimicrobial Resistance in Staphylococcus 18
-
- Urinary Tract Infections Management 17
Tom Bergan
271 papers receiving 3.9k citations
Peers
Comparison fields: 5 of 162
- Molecular Medicine 942
- Pharmacology 1.6k
- Hardware and Architecture 501
- Applied Microbiology and Biotechnology 136
- Clinical Biochemistry 337
Countries citing papers authored by Tom Bergan
This map shows the geographic impact of Tom Bergan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tom Bergan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tom Bergan more than expected).
Fields of papers citing papers by Tom Bergan
This network shows the impact of papers produced by Tom Bergan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tom Bergan. The network helps show where Tom Bergan may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Tom Bergan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2010 | 92 | |
| 2 | 1999 | 36 | |
| 3 | 1996 | 8 | |
| 4 | 1991 | 16 | |
| 5 | 1990 | 52 | |
| 6 | 1987 | 14 | |
| 7 | 1986 | 3 | |
| 8 | 1986 | 7 | |
| 9 | 1986 | 60 | |
| 10 | 1985 | 4 | |
| 11 | 1983 | 1 | |
| 12 | 1983 | 18 | |
| 13 | Production and purification of the thermolabile enterotoxin of Escherichia coli. | 1980 | 4 |
| 14 | 1979 | 19 | |
| 15 | [Amikacin and tobramycin]. | 1978 | 1 |
| 16 | Kinetics of tissue penetration. Are high plasma peak concentrations or sustained levels preferable for effective antibiotic therapy? | 1978 | 30 |
| 17 | [Heparin induced thrombocytopenia--an investigation in Norweigan patients]. | 1978 | 3 |
| 18 | Epidemiological markers for Pseudomonas aeruginosa. 3. Comparison of bacteriophage typing, serogrouping. and pyocine typing on a heterogeneous clinical material. | 1973 | 8 |
| 19 | Epidemiological markers for Pseudomonas aeruginosa. 2. Relationship between bacteriophage susceptibility and serogroup or pyocine type. | 1973 | 3 |
| 20 | Reisolation of Micrococcus mucilaginosus Migula 1900. | 1970 | 27 |
About Tom Bergan
Tom Bergan is a scholar working on Molecular Medicine, Pharmacology, Transplantation, Clinical Biochemistry and Endocrinology, having authored 281 papers that have together received 4.4k indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (118 papers), Antibiotic Resistance in Bacteria (53 papers), Drug Transport and Resistance Mechanisms (19 papers), Pharmaceutical studies and practices (18 papers), Antimicrobial Resistance in Staphylococcus (18 papers), Bacterial Identification and Susceptibility Testing (18 papers), Parallel Computing and Optimization Techniques (18 papers) and Urinary Tract Infections Management (17 papers). The work is most often cited by research in Molecular Medicine (942 citations), Pharmacology (1.6k citations), Hardware and Architecture (501 citations), Applied Microbiology and Biotechnology (136 citations) and Clinical Biochemistry (337 citations). Tom Bergan has collaborated with scholars based in Norway, United States and Sweden. Frequent co-authors include Luís Ceze, R. Rohwedder, Dan Grossman, Sigurður B. Þorsteinsson, Joseph Devietti, Owen T. Anderson, E. K. Brodwall, M. Kocur, Hideyuki Matsumoto and Sune Thorsteinsson. Their work appears in journals such as Chemotherapy, Infection, Journal of Antimicrobial Chemotherapy, European Journal of Clinical Microbiology & Infectious Diseases and Antimicrobial Agents and Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.